Purpose: Transurethral catheterization is restricted to fewer procedures and a limited time with an increase in enhanced recovery after surgery (ERAS) programs or fast-track surgical procedures. We aim to evaluate the feasibility of immediate removal of transurethral catheter in hemodymically stable patients undergoing radical gastrectomy prior to a prospective randomized control trial. Methods: A total 63 gastric cancer patients undergoing elective radical gastrectomy were enrolled in a feasibility study. Patients were randomized to either the active group (immediate removal group) or control group (removal at postoperative day 1 group) with blinding, and 58 patients were finally included. Amount of residual and voiding urine, operative factors (operation time, infused fluid, urine output, and blood loss), first voiding discomfort level, urinary discomfort score, and urine analysis were measured. Results: In the active group, the self-voiding volume and residual urine volume measured nearly equal (256 ml vs 244 ml) at 16 hours after transurethral catheter removal. The discomfort score of first self-voiding was lower in active group (P=0.041). Regarding urinary discomfort at postoperative day 2 and the urine analysis at postoperative day 5, there were no significant differences between the 2 groups. Conclusion: Immediate removal of the transurethral catheter could be feasible and safe in hemodynamically stable patients undergoing radical gastrectomy in aspects of ERAS programs. A prospective randomized controlled trial would be scheduled for acceptable evidence. 
INTRODUCTION
In major surgery such as radical gastrectomy in gastric In this aspect, unneccessay urinary catheterization for long periods is a major disturbance for early recovery. (4, 5) In particular, anxiety for aggravation of urinary tract pain at ambulation and intricate transurethral catheter system including the collection bag are important disturbance.
For restriction of transurethral catheterization, the most serious clinical problem is APOUR. So, awareness and selection of patients at risk of developing APOUR would be of great significance. It has been suggested that bladder catheterization should be advised in high-risk subjects when the bladder volume is greater than 600 ml over a minimum period of 2 hours. (1) Our hypothesis is that empirical long-term use of transurethral bladder catheterization is not mandatory for all patients undergoing radical gastrectomy. Recently, radical gastrectomy is not considered to be high risk surgery any more, because the duration is not long, and massive bleeding during surgery is rare. In this study, we aimed to evaluate the feasibility of immediate removal of transurethral catheter in hemodynamically stable patients undergoing radical gastrectomy, prior to a prospective randomized controlled trial (RCT).
METHODS

1) Study setting
This feasibility study was performed at a single institute.
All patients gave their written consent for this study after receiving a full explanation of the study including the purpose, potential benefits and complications.
2) Patients
A total 63 gastric cancer patients undergoing elective radical gastrectomy in Seoul St. Mary's Hospital were enrolled for feasibility study. A complete history and physical examination were undertaken for all possible candidates to determine eligibility for inclusion. There were no specific inclusion or exclusion criteria for this feasibility study, but a total 5 patients were excluded for safety reasons. The reasons of exclusion were old age (over 75 year old; n=2), high prostate-specific antigen (PSA) level (n=2), severe chronic disease (liver cirrhosis-child B; n=1).
There were no hemodynamically unstable patients needing intensive care unit (ICU) care after radical gastrectomy in the included patients.
A total 58 patients were included in this study. In the process of the study, 6 cases were dropped out in active group, and 2 cases were dropped out in control group.
Finally, 25 patients were included for analysis in both groups, respectively (Fig. 1 ).
3) Patient grouping and protocols according to groups
All patients were randomized to either active group (immediately removal group) or control group (removal at postoperative day 1 group). Patient's blinding was undertaken within this feasible study design. The results of urinary analysis before discharge were compared with the results of preoperative urinary analysis, and positive finding was represented a case which was newly developed state in postoperative urine analysis.
All transurethral catheterizations (Foley
5) Statistics
This study was designed to confirm feasibility. The urinary discomfort was measured by a structured questionnaire using the McGill Pain Questionnaire at postoperative day 2 (POD 2), and the measured score recorded categorically (0∼4) and reclassified 2 categories (0∼1, negative; 2∼4, positive). ‡ The urine analysis was performed at postoperative day 5 (POD 5) before discharge by dipstick exam and bacterial culture.
were performed using SPSS software (Ver. 13.0) and a P-value＜0.05 was considered to indicate a statistically significant difference with a 95% confidence interval (95% CI).
RESULTS
There were no significant differences between the 2 groups regarding age, sex, and operative factors (Table 1 ).
In the process of the study, 6 cases were dropped out in active group, and 2 cases were dropped out in control group, respectively. These 8 patients were diagnosed with APOUR according to our criteria. The incidence of APOUR was 19.4% in active group (6/31), and 7.4% in control group (2/27), respectively.
In the active group, the mean volume of self-voiding after 4 hours was 164 ml, and RU measured was 283 ml.
The self-voiding volume increased gradually, and the residual volume decreased over time. However, the selfvoiding and RU volume was measured nearly equal (256 ml vs. 244 ml) 16 hours after transurethral catheter removal, and showed difference of volume after 24 hours (Fig. 2) .
Regarding the degree of first self-voiding discomfort after removal of transurethral catheter, there were significant differences between the 2 groups. The VAS score (degree of first self-voiding discomfort) was lower in active group compared to control group (P=0.041) ( Table 2) .
Regarding the urinary discomfort at POD 2 and the urine analysis at POD 5, there were no significant differences between the 2 groups ( Table 2) . (1,9-12) However, radical gastrectomy in hemodynamically stable patients has not been included as risky surgery for APOUR any more, because it is not lower abdominopelvic surgery, the duration is not long, and no longer requires large volumes of intravenous fluid. In this studys, the duration of surgery was shorter than the presented risk factor (200.5±39.7 min in control group, 190.7±39.9 min in active group), and total amount of blood loss averaged less than 300 ml in both groups.
Moreover, the urinary bladder could be completely emptied by bladder catheterization during operation. Therefore, we hypothesized that empirical long-term use of transurethral bladder catheterization is not mandatory for all patients undergoing radical gastrectomy, and decided to perform a prospective RCT for evidence. But, we also think that the age and gender factors should be controlled with adequate enroll criteria under the ethic point of view in RCT.
The overall incidence of APOUR has been reported to be between 14% and 30.2% regardless of the type of abdominopelvic surgery. One of the important reason of marked differences among the studies is that there have been controversies about the definition of APOUR. (12) (13) (14) In this study, the incidence of APOUR was respectively 19.4% in active group, and 7.4% in control group with our provisional criteria (A case which undergone in-out transurethral catheter drainage or recatheterizations with transurethral catheter). These results are comparable with other reported outcomes. In active group, 4 patients had transient in-out catheterization, and 2 patients had transurethral catherization. We think that the former (4 patients) resulted from relatively provisional lower criteria (RU was estimated to be over 400 ml in portable bladder ultrasound devices) for performing in-out catheterization compared with other previous studies. The adult urinary bladder has a capacity of 400 to 600 ml, and only 13% of patients required transurethral catheterization due to inability to void among the patients assessed with bladder ultrasound to have a bladder volume greater than 400 ml.(11) Moreover, it was presented that in-out catheterization should be recommended if the volume assessed by bladder ultrasound is more than 600 ml in high-risk patients.
(1) Therefore, we think that the criteria for yeasts. (19) In these studies, incidence of pyuria was below 15% in both groups without significant difference, and incidence of bacteriuria did not show significant difference.
But, the incidence of bacteriuria was relatively high in both groups (20% and 32%, respectively) because there was cultured normal flora in women.
In conclusion, the results of this study showed that the immediate removal of transurethral bladder catheterization after radical gastrectomy could be safe and feasible in hemodynamically stable patients undergoing radical gastrectomy in aspect of ERAS program. The prospective RCT would be scheduled under the Institutional Review Board (KC09OISI0225) supervision for acceptable evidences.
